Director/Senior Director Global Program Safety Physican (US/EU/IL)

Sorry, this job was removed at 10:12 p.m. (UTC) on Friday, Aug 08, 2025
Be an Early Applicant
29 Locations
Remote
Biotech
The Role
About Prilenia
 
Prilenia, a private biopharmaceutical company with a highly committed and talented global team, is seeking a Director/Senior Director Global Program Safety in Regulatory, located in Europe or Israel.

Being part of Prilenia is being a part of a simple but urgent mission – the development of transformative medicines for people affected by devastating neurodegenerative diseases. Driven by an unwavering commitment to scientific excellence, Prilenia is developing pridopidine, a first-in-class potentially neuroprotective sigma-1 receptor (S1R) agonist, which, if approved by the EMA later this year, could be the first approved drug to impact clinical disease progression and not just manage symptoms.
 
Prilenia holds Orphan Drug designation for pridopidine in HD and ALS in the U.S. and EU. In addition, pridopidine has received Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment of HD. The European Medicines Agency (EMA) has accepted for review Prilenia’s European Marketing Authorisation Application (MAA) seeking regulatory approval of pridopidine for the treatment of HD. This is the first submission seeking approval for a potential treatment that can impact clinical progression in HD. For ALS, Prilenia also plans to initiate a pivotal Phase 3 trial to evaluate pridopidine.
To learn more about our story and company culture, visit us at https://Prilenia.com 
 
 
About the role

We seek a highly qualified and experienced professional to join our team as Director/Senior Director, Global Program Safety Physician (GPSP). This position assists in the successful development, execution and maintenance of safety-related strategies that conform to industry standards and compliance with global regulations. The ideal candidate will have profound experience in Drug Safety & Pharmacovigilance and Risk Management in pharmaceutical company in both clinical and post-marketing. This position will report to the Chief Regulatory and Commercialization Officer.

Roles and Responsibilities:

  • Provide strategic Patient Safety input to drug development and post-marketing programs of the given product.
  • Compile safety information for clinical overviews, post-marketing safety assessment, risk management plans, labeling justifications, CCSI development and written summaries of clinical safety of common technical documents.
  • Undertake and prepare high-quality evaluation documents to describe safety findings in collaboration with external vendors (when applicable).  
  • Leads and reviews PV aggregate safety reports for assigned product(s) (e.g., DSUR, PBRER/PSUR), including safety database requests, working with the report's authors, and ensuring effective planning in accordance with the regulatory timelines.
  • Responsible for preparation and maintenance of core safety information as used for Investigator's brochures and labeling.
  • Lead the signal detection activities including safety surveillance activities, medical review and benefit-risk assessment of assigned product(s). 
  • Support the development of risk management strategies for investigational     compounds.
  • Address safety questions from Regulatory Authorities.
  • Chair the multidisciplinary Safety Management Team whose responsibilities include safety surveillance (signal detection and evaluation), risk management planning, and making recommendations related to safety issues.
  • Provide leadership to support project discussions with governance boards, including interactions with Medical Safety Review Council and leads the safety strategy for regulatory communication.   
  • Provide regular updates on safety data trending, signaling and other safety related issues to the Medical Safety Review Council (MSRC) and recommend pharmacovigilance / risk management actions on behalf of the Medical Safety Team. 
  • Support PV audits and inspections by participating in audit readiness activities and serving as subject matter expert during regulatory inspections.  

Qualifications:

  • A Medical degree with clinical experience is required.
  • Must have 7+ years of profound experience in Drug Safety & Pharmacovigilance and Risk Management in pharmaceutical companies in both clinical and post-marketing. Experience in non-clinical is desirable.
  • Experience in rare diseases and neurology preferred.
  • Experience in signal detection with demonstrated experience in analysis, and interpretation of medical and scientific data.
  • Experience in safety data analysis and writing product-related aggregate reports and safety assessments.
  • Experience in the design, implementation, tracking and follow up of risk management plans.
  • Experience in MedDRA coding and search strategies.
  • Knowledge of regulations and guidance (EU, US and global).
  • Direct experience in interacting with Health Authorities preferred.
  • New product launch experience desired.

Skills:

  • Ability to apply clinical judgment to interpret case information.
  • Ability to synthesize large amounts of medical data and draw medical conclusions.
  • Excellent interpersonal and communication skills (both written and oral) required.
  • Demonstrated ability to work effectively in a cross-functional team environment (including Safety, Clinical Development, Medical Affairs, Clinical Operations, and Regulatory), as well as independently.
  • Attention to detail and the ability to work individually, within a multi-disciplinary team, as well as with external partners and vendors.
  • Strong knowledge of international regulatory requirements including ICH, European Pharmacovigilance legislation, FDA and CIOMS.
  • Project management skills preferred.

Location/Time Zones:

       This is a full-time remote position with occasional in-person/face-to-face meetings.
       Flexible schedule with interactions across Israel, North America and Europe time zones.
       Occasional international travel is required

Prilenia operates across the United States, Canada, Europe and Israel, is incorporated in the Netherlands and backed by leading life sciences investors. We are a highly flexible organization that is mostly remote and encourages team members to work in the ways that make them most effective, with a focus on our common goals and getting the job done.
 
Prilenia is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status. We are dedicated to fostering a diverse, inclusive, and welcoming workplace for all. 

Similar Jobs

Shield AI Logo Shield AI

Solutions Engineer

Aerospace • Artificial Intelligence • Machine Learning • Robotics • Software
Remote
Athens, GRC

Mondelēz International Logo Mondelēz International

Talent Acquisition Advisor Greece

Big Data • Food • Hardware • Machine Learning • Retail • Automation • Manufacturing
Remote or Hybrid
3 Locations
90000 Employees

Mondelēz International Logo Mondelēz International

Marketing Lead Bulgaria

Big Data • Food • Hardware • Machine Learning • Retail • Automation • Manufacturing
Remote or Hybrid
3 Locations
90000 Employees

Mondelēz International Logo Mondelēz International

o9 Change Readiness Lead

Big Data • Food • Hardware • Machine Learning • Retail • Automation • Manufacturing
Remote or Hybrid
11 Locations
90000 Employees
Get Personalized Job Insights.
Our AI-powered fit analysis compares your resume with a job listing so you know if your skills & experience align.

The Company
HQ: Herzliya
41 Employees
Year Founded: 2018

What We Do

Prilenia is a clinical-stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders. Our lead asset is Pridopidine, a first-in-class oral drug candidate with an established safety profile and potential in multiple movement disorders and neurodegenerative diseases affecting adults and children. Pridopidine is currently being evaluated for the treatment of Huntington’s disease in our global Phase 3 PROOF-HD trial, and for the treatment of ALS in the Phase 2/3 HEALEY platform trial. The company is led by Dr. Michael Hayden, MD, PhD, the founder of five biotech companies and previous President of Global R&D and Chief Scientific Officer at Teva. Michael has directed the development of multiple innovative drug products, leading to 35 approvals between 2012-2018. The Company is based in Naarden, the Netherlands, Herzliya, Israel and Boston, MA in the U.S.

Similar Companies Hiring

Formation Bio Thumbnail
Artificial Intelligence • Big Data • Healthtech • Biotech • Pharmaceutical
New York, NY
150 Employees
SOPHiA GENETICS Thumbnail
Software • Healthtech • Biotech • Big Data • Artificial Intelligence
Boston, MA
450 Employees
Pfizer Thumbnail
Artificial Intelligence • Healthtech • Machine Learning • Natural Language Processing • Biotech • Pharmaceutical
New York, NY
121990 Employees

Sign up now Access later

Create Free Account

Please log in or sign up to report this job.

Create Free Account